Found: 4
Select item for more details and to access through your institution.
ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and prognostic marker for visceral leishmaniasis and human immunodeficiency virus coinfection.
- Published in:
- Parasitology Research, 2021, v. 120, n. 12, p. 4037, doi. 10.1007/s00436-021-07342-1
- By:
- Publication type:
- Article
A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against Leishmania infantum Infection.
- Published in:
- Vaccines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/vaccines10071146
- By:
- Publication type:
- Article
A Combined Strategy to Improve the Development of a Coral Antivenom Against Micrurus spp.
- Published in:
- Frontiers in Immunology, 2019, v. 10, p. 1, doi. 10.3389/fimmu.2019.02422
- By:
- Publication type:
- Article
A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00224-0
- By:
- Publication type:
- Article